IASLC Awards James D. Cox Lectureship Award for Radiation Oncology to Yuko Nakayama at the World Conference on Lung Cancer

IASLC Awards James D. Cox Lectureship Award for Radiation Oncology to Yuko Nakayama at the World Conference on Lung Cancer

Press Release
Aug 05, 2022

Contact: Chris Martin, IASLC Media Relations, cmartin@davidjamesgroup.com, 630.670.2745

VIENNA, Austria (August 6, 2022) ⎯ Yuko Nakayama was awarded the James D. Cox Lectureship Award for Radiation Oncology today at the 2022 IASLC World Conference on Lung Cancer.

Dr. Yuko Nakayama is Chief of the Department of Radiation Oncology at the National Cancer Center Hospital in Tsukiji, Japan. 

She was promoted to Assistant Professor of Radiation Oncology at Gunma University, and then Associate Professor of Radiation Oncology at Tokai University. Throughout her career, she has specialized in the treatment of lung cancer with (chemo) radiotherapy.  

She was appointed Chair of Radiation Oncology at Kanagawa Cancer Center (KCC) in 2008, and immediately began preparations for the construction of a carbon-ion radiotherapy facility; this facility began operation in 2015. She was in charge of both conventional photon radiotherapy as well as carbon-ion therapy at KCC. 

She is a member of the Board of Directors of the Japan Lung Cancer Society (JLCS), and has served as vice-chair and chair of the Lung Cancer Guideline Committee, and chair of the Lung Cancer Guideline Sub-Committee in the field of radiotherapy. She was also a member of the Guideline Committee of the Japanese Society of Radiation Oncology (JASTRO).  

Recently, she published a paper on the CT atlas for defining regional lymph node stations in radiotherapy for lung cancer as a member of the joint committee of JLCS and JASTRO. The standardization of radiotherapy for lung cancer is one of her lifeworks. 

###

About the IASLC

The International Association for the Study of Lung Cancer (IASLC) is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 7,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis, and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Share